Workflow guide · Daily research
How Biotech Analysts Build a Daily Research Briefing
Convert overnight company and industry updates into a prioritized coverage briefing before deeper research begins.
The situation
When this workflow becomes useful
An analyst covers a defined company universe but must also understand competitor developments and sector-wide events before the morning meeting.
Best fit
Sell-side, buy-side, independent, and corporate analysts responsible for ongoing biotech company or therapeutic-area coverage.
The challenge
Why the obvious approach breaks down
The analyst needs to scan broadly without allowing routine headlines to crowd out material evidence or consume the entire research day.
How to think about the task
The reasoning behind the workflow
An analyst briefing should connect overnight events to the existing coverage model. The useful unit is not the headline but the change in evidence, timing, financial position, or competitive context. That change determines whether the item needs a model update, a source check, a client note, or no action.
The briefing also serves as a memory system. When the daily output is linked back to company and peer timelines, repeated guidance changes and accumulating competitive evidence become easier to see.
Use separate coverage rings
Active coverage names deserve the fastest and deepest review. Watchlist companies can receive event-level monitoring, while broader peers may be captured through targets, modalities, and indications. These rings prevent a broad universe from receiving identical attention.
State the delta and the analytical consequence
A concise item should say what changed, which prior assumption it touches, and what follow-up is required. This format allows another team member to understand the significance without reading every source immediately.
Archive what may matter later
Material items should flow into a company or landscape timeline. A daily brief becomes far more valuable when it helps reconstruct management execution, clinical evidence, and competitor movement during later catalyst preparation.
Illustrative example
Illustrative coverage morning
An analyst sees earnings from a covered company, data from a target peer, and a financing by a watchlist name. The briefing flags the covered company’s changed runway, identifies the peer result as possible target validation, and records the financing without deeper work because it does not alter the current watchlist question.
Each item receives a different action even though all three are legitimate news. The brief reflects research priority rather than publication volume.
Questions to answer before making a decision
- What changed versus the last known state?
- Is the item direct coverage, competitive read-through, or background?
- What follow-up or model change is required?
- Should this event enter a permanent timeline?
The workflow
A repeatable way to do the work
- 01
Create separate lists for active coverage, watchlist companies, and competitive peers.
- 02
Prioritize events by coverage relevance, evidence strength, and urgency.
- 03
Add one sentence describing what changed versus the previous known state.
- 04
Flag indirect read-throughs and assign deeper follow-up where needed.
- 05
Archive the briefing into company timelines so useful context compounds over time.
Monitoring checklist
Signals to keep visible
Common mistakes
- Summarizing headlines without identifying what is new
- Ignoring non-coverage competitors
- Treating the daily brief as disposable
Output and outcome
What good looks like
Deliverable
A morning briefing ranked by urgency, with coverage impact, read-through notes, source links, and assigned research actions.
Practical outcome
The analyst starts deeper work with a current market map and builds a reusable evidence trail instead of repeating the same source collection.
Where BioPharmSignal fits
Reduce the collection work around the decision.
Use LiveFeed and company pages for source-linked monitoring, the PDUFA Calendar for upcoming FDA milestones, and watchlists or alerts to keep the relevant tickers and keywords visible. The workflow still requires independent research and judgment.
Frequently asked questions
Who is this workflow for?
It is designed for biotech research analysts and adjacent biotech research users who need a repeatable, source-linked way to complete this task.
What should this workflow produce?
A morning briefing ranked by urgency, with coverage impact, read-through notes, source links, and assigned research actions.
What is the practical benefit?
The analyst starts deeper work with a current market map and builds a reusable evidence trail instead of repeating the same source collection.
Related workflows